We are not aware of any large prospective population-based study investigating mood, chronic disease, lifestyle and demographic factors together as predictors of long-term CWP persistence.
When instruments have been developed such as the Color Pyramid test,[ 14] the Rorschach Inkblot test,[ 15] the Lüscher Color test,[ 16] the Lowenfeld Mosaic test[ 17] and the Stroop test[ 18] they have been designed more to interpret, for instance personality or cognitive processing, rather than allowing a subject to simply select a single color to represent their mood or disease.
Several other major human diseases including mood disorders, Alzheimer disease, and osteoporosis may involve reduced β-catenin signaling [1].
There is a complex interplay between cognitive decline (particularly in the context of 'small vessel disease'), mood disorder and systemic vascular disease that is poorly understood but likely to be relevant to HF. Mood disorders are particularly important to detect as they can respond to intervention, making mood disorder in HF a potentially treatable form of cognitive decline.
Therefore, cognitive flexibility is likely to be associated with psychotic features, mood state and disease course.
However, subgroups within the spectrum as well as psychopathological features, current mood state/euthymia and disease stage might be confounding factors.
Glycogen synthase kinase 3β (GSK-3β) is widely recognised as a relevant player in the pathogenesis of several highly prevalent disorders such as Alzheimer's disease, mood disorders, diabetes and cancer.
OSA has been associated with an increased risk for myriad health problems, including hypertension, heart disease, mood and memory problems.
Dr. Rezai's research focuses on neural circuitry, and development of neurological sensors and monitors, surgical tools and technologies, and new therapeutic applications such as neurostimulation for Parkinson's disease, mood and anxiety disorders, traumatic brain injury, obesity and headaches.
These data suggest that hormonal status can influence mood and cardiovascular disease independently, even when co-expressed.
